Primary, secondary and tertiary prevention of food allergy: current practices and future directions

被引:3
|
作者
Cronin, Caoimhe [1 ,2 ,3 ]
Salzberg, Noah [1 ]
Woon, Yuxin [2 ]
Wurttele, Juan Trujillo [1 ,2 ,3 ]
机构
[1] Univ Coll Cork, Dept Paediat & Child Hlth, Cork, Ireland
[2] Cork Univ Hosp, Dept Paediat, Cork, Ireland
[3] Cork Univ Hosp, Irish Ctr Maternal & Child Hlth Res INFANT, HRB Clin Res Facil Cork CRF C, Cork, Ireland
关键词
dietary advancement therapy; food allergy; paediatrics; prevention; immunotherapy; PEANUT ORAL IMMUNOTHERAPY; SUBLINGUAL IMMUNOTHERAPY; RANDOMIZED-TRIAL; DOUBLE-BLIND; CHILDREN; RISK; SENSITIZATION; CONSUMPTION; INFANTS; DIET;
D O I
10.15586/aei.v52i2.1023
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
The incidence of food allergies has risen around the globe, and experts have been exploring methods of preventing such allergies in young children to ease the burden of disease and reduce the morbidity and mortality caused by anaphylaxis to food allergens. Such preventative measures can be categorised as primary, secondary and tertiary prevention, which discussed in detail in this review. Primary prevention is defined as the prevention of becoming sensitised towards specific allergens. The evidence suggests that avoiding common allergenic foods during pregnancy and breastfeeding is not protective against food allergies, and guidelines recommend weaning from 4 to 6 months of age, with recent studies supporting the early introduction of peanuts at 4 months to prevent peanut allergy. Secondary prevention targets patients who are already sensitised and aims to halt the progression of sensitisation, with evidence for high rates of success and safety in trials of early introduction to milk and peanuts using oral immunotherapy in sensitised infants. Tertiary allergy prevention focuses reducing the risk of a patient having anaphylaxis, with oral immunotherapy being the most common method of promoting tolerance in allergic children. Several studies have demonstrated successful reintroduction for milk, egg and peanut; however, no such guidelines recommended for other foods. Finally, dietary advancement therapy in the form of milk and egg ladders has been employed as a method of primary, secondary and tertiary prevention allergies, particularly in Ireland, the UK and Canada. (c) 2024 Codon Publications. Published by Codon Publications.
引用
收藏
页码:32 / 44
页数:13
相关论文
共 50 条
  • [1] Food allergy and the microbiome: Current understandings and future directions
    Bunyavanich, Supinda
    Berin, M. Cecilia
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 144 (06) : 1468 - 1477
  • [2] Food allergy: Current knowledge and future directions - Preface
    Burks, AW
    James, JM
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 1999, 19 (03) : XI - XII
  • [3] Food allergy and risk assessment: Current status and future directions
    Remington, Benjamin C.
    59TH INTERNATIONAL MEAT INDUSTRY CONFERENCE MEATCON2017, 2017, 85
  • [4] Food allergy, environment and primary and secondary prevention of atopic dermatitis
    Thi, NP
    De Blic, J
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2005, 132 : 228 - 242
  • [5] Oral and sublingual immunotherapy for food allergy: current progress and future directions
    Moran, Timothy P.
    Vickery, Brian P.
    Burks, A. Wesley
    CURRENT OPINION IN IMMUNOLOGY, 2013, 25 (06) : 781 - 787
  • [6] Primary Prevention in Mental Health - Current Evidence and Future Directions
    Almeida, Diogo
    Maia, Teresa
    PSILOGOS, 2021, 19 (1-2) : 57 - 74
  • [7] Primary Prevention of Food Allergy
    Greenhawt, Matthew J.
    Fleischer, David M.
    CURRENT ALLERGY AND ASTHMA REPORTS, 2017, 17 (04)
  • [8] Primary Prevention of Food Allergy
    Matthew J. Greenhawt
    David M. Fleischer
    Current Allergy and Asthma Reports, 2017, 17
  • [9] Primary Prevention of Food Allergy
    Rachel L. Peters
    Melanie R. Neeland
    Katrina J. Allen
    Current Allergy and Asthma Reports, 2017, 17
  • [10] Primary Prevention of Food Allergy
    Kumfer, Ann Marie
    Commins, Scott P.
    CURRENT ALLERGY AND ASTHMA REPORTS, 2019, 19 (01)